3D image of stomach and instetines

Palisade Bio Collaboration to Advance Precision Medicine for Ulcerative Colitis

Biopharmaceutical company, Palisade Bio, Inc. (Nasdaq: PALI) has entered into a strategic collaboration with Strand Life Sciences, a leading bioinformatics specialist, to advance precision medicine for ulcerative colitis (UC) therapy. The company’s share price rose nearly 30% in intraday trading following the news. The collaboration will provide Palisade Bio with access to advanced bioinformatics tools… [Read More]

Magnificent Seven’ Prepares to Announce Earnings Amid Market Recovery

Tesla Ends Week-Long Slide Before Earnings; Bond Market Stabilizes After $69 Billion Treasury Sale As tech giants brace to release their earnings, the broader stock market is witnessing a rally, led by the much-watched ‘Magnificent Seven.’ Wall Street views these forthcoming earnings as a critical test of the ongoing equities bull run. Each member of… [Read More]

It Takes More Than a Village to Raise a Successful Company: Village Farms (VFF) Continues to Gain National Share, up 71% YTD.

The Canadian cannabis company Village Farms International, Inc. (VFF) has returned 71% YTD, is up 26% in the past month and has returned 78% over the past year. Village Farms continues to report its successes and make recent headlines to stay budding in investors’ minds. Growing Greens and Gaining Share The ganja grower has gained… [Read More]

Spotify jumps starts the spring with a gain

Spotify Technologies (NYSE: SPOT), a renowned audio-streaming platform, saw a notable rise in its share prices on Tuesday post their Q1 2024 financial results announcement. At 9:40 a.m. ET, the company’s stock had soared by 13% and was reaching new 52-week highs. Achieving Profits through Steady Growth Spotify closed Q1 with 615 million monthly active… [Read More]

S&P 500 Surpasses 5,000 Amid Strong Big Tech Performance: Weekly Market Overview

As the S&P 500 tops 5,000, led by significant movements in the technology sector, the markets enter a pivotal week. This week is set to be the busiest for first-quarter earnings, with approximately 180 S&P 500 companies—accounting for over 40% of the index’s market cap—scheduled to report their results. High expectations are set for the… [Read More]

FDA Places Hold on Neumora Schizophrenia Study

The FDA has placed a clinical hold on Neumora Therapeutics’ (Nasdaq: NMRA) Phase 1 trial of NMRA-266 after the compound resulted in convulsions in rabbits in the company’s preclinical studies. The company’s stock tumbled 17.5% to close at $11.19 after the announcement last week. The stock closed down an additional 3.51% on Friday and has… [Read More]

M&A Moves: Matterport (MTTR) To Be Acquired By CoStar Group, Stock Up 176% On Report

Today the technology company specializing in creating immersive 3D experiences of physical spaces Matterport, Inc. (MTTR) announced today that it has entered into a definitive agreement with CoStar Group, Inc. (CSGP) who will acquire all of Matterport’s outstanding shares in a cash and stock transaction valued at $5.50 per share. This represents an equity value of… [Read More]

YS Biopharma to Initiate Hepatitis B Vaccine Trial in Philippines

Global biopharmaceutical company, YS Biopharma (Nasdaq: YS) has been granted clinical trial approval in the Philippines for its YS-HBV-002 immunotherapeutic vaccine for chronic hepatitis B virus (HBV) infection. YS expects to initiate a Phase 1 clinical trial in the Philippines in June 2024. Chronic HBV infection is a significant unaddressed public health threat, with 1.2… [Read More]